Warning: The NCBI web site requires JavaScript to function. more...
Inhibition of poly (ADP-Ribose) polymerase-1 in telomerase deficient mouse embryonic fibroblasts increases arsenite-induced genome instability.
Gurung RL, Balakrishnan L, Bhattacharjee RN, Manikandan J, Swaminathan S, Hande MP.
Genome Integr. 2010 May 26;1(1):5.
Related citations
Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite.
Poonepalli A, Balakrishnan L, Khaw AK, Low GK, Jayapal M, Bhattacharjee RN, Akira S, Balajee AS, Hande MP.
Cancer Res. 2005 Dec 1;65(23):10977-83.
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Short dysfunctional telomeres impair the repair of arsenite-induced oxidative damage in mouse cells.
Newman JP, Banerjee B, Fang W, Poonepalli A, Balakrishnan L, Low GK, Bhattacharjee RN, Akira S, Jayapal M, Melendez AJ, Baskar R, Lee HW, Hande MP.
J Cell Physiol. 2008 Mar;214(3):796-809.
DNA repair factors and telomere-chromosome integrity in mammalian cells.
Hande MP.
Cytogenet Genome Res. 2004;104(1-4):116-22. Review.
Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability.
d'Adda di Fagagna F, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP.
Nat Genet. 1999 Sep;23(1):76-80.
Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.
Löser DA, Shibata A, Shibata AK, Woodbine LJ, Jeggo PA, Chalmers AJ.
Mol Cancer Ther. 2010 Jun;9(6):1775-87. Epub 2010 Jun 8.
Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase-deficient mice and primary cells despite increased chromosomal instability.
Samper E, Goytisolo FA, Ménissier-de Murcia J, González-Suárez E, Cigudosa JC, de Murcia G, Blasco MA.
J Cell Biol. 2001 Jul 9;154(1):49-60.
Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage.
Ding W, Liu W, Cooper KL, Qin XJ, de Souza Bergo PL, Hudson LG, Liu KJ.
J Biol Chem. 2009 Mar 13;284(11):6809-17. Epub 2008 Dec 3.
Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs.
Espejel S, Klatt P, Ménissier-de Murcia J, Martín-Caballero J, Flores JM, Taccioli G, de Murcia G, Blasco MA.
J Cell Biol. 2004 Nov 22;167(4):627-38. Epub 2004 Nov 15.
DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression.
Tong WM, Hande MP, Lansdorp PM, Wang ZQ.
Mol Cell Biol. 2001 Jun;21(12):4046-54.
The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM, Willmore E, Austin CA, Curtin NJ.
Clin Cancer Res. 2005 Dec 1;11(23):8449-57.
Functional interaction between poly(ADP-Ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2.
Dantzer F, Giraud-Panis MJ, Jaco I, Amé JC, Schultz I, Blasco M, Koering CE, Gilson E, Ménissier-de Murcia J, de Murcia G, Schreiber V.
Mol Cell Biol. 2004 Feb;24(4):1595-607.
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor.
Tentori L, Portarena I, Barbarino M, Balduzzi A, Levati L, Vergati M, Biroccio A, Gold B, Lombardi ML, Graziani G.
Mol Pharmacol. 2003 Jan;63(1):192-202.
Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.
Min W, Cortes U, Herceg Z, Tong WM, Wang ZQ.
Carcinogenesis. 2010 Dec;31(12):2058-65. Epub 2010 Oct 6.
DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines.
Trucco C, Oliver FJ, de Murcia G, Ménissier-de Murcia J.
Nucleic Acids Res. 1998 Jun 1;26(11):2644-9.
Exploiting the Achilles heel of cancer: the therapeutic potential of poly(ADP-ribose) polymerase inhibitors in BRCA2-defective cancer.
Kyle S, Thomas HD, Mitchell J, Curtin NJ.
Br J Radiol. 2008 Oct;81 Spec No 1:S6-11.
ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG, Benchimol S.
EMBO J. 1997 Oct 1;16(19):6018-33.
Defective control of mitotic and post-mitotic checkpoints in poly(ADP-ribose) polymerase-1(-/-) fibroblasts after mitotic spindle disruption.
Halappanavar SS, Shah GM.
Cell Cycle. 2004 Mar;3(3):335-42. Epub 2004 Mar 1.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on